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Objective：This study is designed to investigate the association of tumorigenesis with DNA repair gene, N-
methylpurine-DNA-glycosylase(MPG) in astrocytic tumors. 
Methods：MPG mRNA expression and localization in the 30 astrocytic tumors and 7 tumor-adjacent brain 
tissues was examined by reverse transcriptase-polymerase chain reaction(RT-PCR) and RNA in situ hybridization. 
Expression and intracellular localization of MPG protein was determined by immunohistochemistry. Statistical 
analysis was performed by ANOVA with a p value<0.05 considered statistically significant. 
Results：MPG mRNA expression in RT-PCR was significantly higher in grade IV tumor tissues than in brain 
tissues adjacent to tumor or in grade II-III astrocytic tumor tissues(p<0.05). MPG mRNA in in situ hybridization 
was detected both in brain tissues adjacent to tumor and in astrocytic tumor tissues, regardless of the tumor grades. 
However, MPG protein localization in immunohistochemical study was detected only in the nucleus of all tumor 
tissues. In brain tissues adjacent to tumor, immunohistochemical study for MPG was not stained both in the nucleus 
and in cytoplasm.  
Conclusion：These results suggest MPG’s role in human astrocytic tumors and raise the possibility that the 
increased mRNA level and intracellular localization could be associated with astrocytic tumorigenesis. Further 
studies about control of MPG gene expression in astrocytic tumors are warranted. 
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Introduction 
 
DNA in all somatic and germ cells in the body are contin-
uously damaged causing mutation, chromosome aberration, 
aging, and carcinogenesis. DNA repair, that is a universal and 
ubiquitous process, is essential for survival of life6,17,32). Mice 
lacking a precise DNA repair activity have been generated, 
and these mutants show various combinations of defective 
embryogenesis, tissue-specific dysfunction, hypersensitivity 
to DNA-damaging agents, premature senescence, genetic in-
stability, and elevated cancer rates10). DNA repair enzymes 
have been reported to play an important role in the carcino-
genesis of several cancers4,13,23,28,29). N-Methylpurine-DNA 
glycosylase(MPG) is one of the key enzyme in DNA repair 
and it removes N-alkylpurine and other related adducts in-
cluding 8-hydroxyguanine, 1,N6-ethenoadenine and hypox-
anthine1,7,26). Expression of MPG is known to be induced by 
viral damage and a variety of DNA-damaging agents such as 
physical agents like UV light and γ-rays, and chemical 
compounds including alkylating, intercalating drugs and 
oxygen free radicals12,23). This enzyme repairs N-alkyladducts 
via a base excision repair pathway in which the first step is 
the removal of the alkyladduct by MPG and AP endonu-
clease16,22,25,26,31). Mitchell and Hartman21) reported that pro-
liferating cells from organs and embryos have a greater DNA 
repair capacity than terminally differentiated and nonproli-
ferating cells. Kim et al.14) also reported that transcription of 
MPG is maximum in rapidly dividing and growing tissues. 
Increased expression of MPG gene was studied in breast 
cancer, cervical neoplasia and thymic carcinoma in SV 40 T-
antigen expressing transgenic mice4,13,29). In breast cancer, 
MPG was overexpressed up to 24-fold as compared to normal 
primary breast epithelium, suggesting the role of MPG in 
breast carcinogenesis4).  
In this study, we tested whether the expression and intra-
cellular localization of MPG could be altered in different 
grade of astrocytic tumors. 
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Methods 
  
Tissues  
Through June 2001 to May 2002, patients with newly 
diagnosed astrocytic tumor consented to use of their tissues. 
All surgical specimens were primary resections and no pa-
tients had received prior radiation or chemotherapy. Tumor 
and tumor-adjacent brain tissue(tumor-adjacent brain tissues； 
N=7；tumor tissues；N=30) were collected. The patient 
materials consisted altogether of 30 patients-13 females and 
17 males, aged 41 to 72 years. Mean age at diagnosis was 54.6 
years ±7.5(SD). All patients underwent craniotomy and 
the study was done on diagnostic material received for frozen 
section and histology. The histological diagnosis was made 
by two neuropathologists. The tissues were classified as 
brain tissues adjacent to tumor, diffuse astrocytoma(grade II), 
anaplastic astrocytoma(grade III) and glioblastoma(grade 
IV) according to World Health Organization(WHO) classifi-
cation of the astrocytic tumors. Of the 30-biopsy samples, 11 
were diagnosed as grade II, 9 as grade III, and 12 as grade IV.  
 
DNA probe and primer preparation 
Semi-quantitative RT-PCR was used to assess mRNA am-
ounts of MPG in tissues, based on the relative expression of 
2 mRNAs：MPG and HPRT(hypoxanthine-guanine phos-
phoribosyltransferase). To normalize mRNA amounts of 
MPG between tissue samples, HPRT, a moderately expressed 
housekeeping gene, was used as the reference gene24). The 
sequence of human MPG was obtained from R. Roy(Uni-
versity of Texas Medical Branch, TX, USA). Primers used 
were MPG sense, 5’-GTCCTAGTCCGGCGACTTCC-3’, 
and anti-sense, 5’-CTTGTCTGGGCAGGCCCTTTGC-3’, 
leading to a 603-bp PCR product, and HPRT sense, 5’-GCC-
GGCTCCGTTATGGCG-3’, and anti-sense, 5’-AGCCCC-
CCTTGAGCACACA-3’, leading to a 225-bp PCR product. 
RT-PCR was carried out using at least triplicates for each 
condition. 
 
Reverse transcriptase-polymerase chain reaction 
To compare the level of MPG mRNA between adjacent 
brain tissues and astrocytic tumors, the total RNA was trans-
cribed into cDNA, and polymerase chain reaction was carried 
out using RT-PCR one batch system(Bioneer Co., Taejon, 
South Korea). The reaction mixture contained 1μg total 
RNA, 20U M-MLV RTase, 10U RNasin, 10mM Tris-Cl(pH 
8.3), 50mM KCl, 10mM MgCl2, 0.5mM dNTP, 10 pmole 
each of 5’ and 3’ primers and 1U Taq polymerase. The reverse 
transcription and PCR amplification was simultaneously per-
formed using Thermal Cycler(PerkinElmer 2400, PerkinEl-
mer Life Sciences Inc., Boston, USA) in one batch tube. The 
reverse transcription was carried out for 60 minutes at 42℃ 
and was heated to 95℃ for 5 minutes to terminate the reverse 
transcription. The amplification was performed for 30 cycles 
of denaturation at 95℃ for 30 seconds, annealing at 64℃ 
for 30 seconds and extension at 72℃ for 30 seconds. A final 
extension step for 5 minutes at 72℃ followed. Aliquots of 
each product were electrophoresed in 1.2% agarose gel con-
taining 0.5μg/ml ethidium bromide. Relative levels of target 
gene(MPG/HPRT) were quantitated by a computerized im-
aging analysis system(Vilber Lourmat, Marne-la-Vallee Ce-
dex 1, France).  
 
RNA in situ hybridization 
The non-radioactive in situ hybridization was performed 
as described by Roche protocol with slight modification27). 
Tissues were formalin fixed and paraffin embedded. Cryostat 
sections of 5μm were collected on ProbeOn Plus slides 
(Fisher Scientific, Pittsburgh, PA, USA) and proteinase K(1
μg/ml) treatment in TE buffer(pH 7.4) for 10 minutes and 
fixed in 4% paraformaldehyde in PBS for 5 minutes. Prehyb-
ridization was performed in a solution of 50% formamide, 
5× SSC, 5× Denhardt’s solution(1mg/ml Ficoll, 1mg poly-
vinylpyrrolidone and 1mg/ml BSA), 250μg/ml tRNA and 
500μg/ml salmon sperm DNA at 62℃ for 2 hours. Hybridi-
zation was performed in the same solution containing 1μg/ml 
digoxigenin-labeled riboprobe at 62℃ overnight. After hy-
bridization, the slides were washed in 2× SSC at 37℃ for 
30 minutes and in 50% formamide/2× SSC at 60℃ for 30 
minutes, and then incubated with NTE solution(500mM 
NaCl, 10mM Tris, 1mM EDTA) containing RNase A(20
μg/ml). And then the slides incubated with blocking buffer 
(10% heat-inactivated normal goat serum, 0.1M Tris, pH 7.5 
and 0.15M NaCl) for 2 hours at room temperature, before the 
addition of alkaline phosphate-conjugated antidigoxigenin 
antibody(1：1,000 dilution in blocking buffer 1：10 diluted 
with maleic acid). After 2 hours incubation at room temper-
ature, the slides were washed three times in maleic acid buffer. 
NBT/BCIP was added as a substrate for alkaline phosphatase, 
after overnight incubation the color reaction was stopped with 
10mM Tris/1mM EDTA. To monitor background level and 
specificity of hybridization, the sense strand of MPG probe 
was used.  
 
Immunohistochemistry 
Surgical specimens were fixed in formalin, dehydrated in 
ethanol, embedded in paraffin, and sectioned by 5μm. Se-
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ctions were deparaffinized with xylene for 3 minutes, quickly 
rehydrated, and microwaved in citrate buffer for 20 minutes 
to enhance antigen retrieval. Endogenous peroxidases were 
blocked by 0.5% peroxide in ethanol. Sections were preincu-
bated with nonimmune goat serum for 10 minutes at the room 
temperature. The primary antibody, monoclonal mouse anti-
MPG, kindly provided from R. Roy(University of Texas 
Medical Branch, TX, USA) was diluted to 1：100 before 
use. The sections were incubated with the primary antibody 
for 2 hours at room temperature. The secondary antibody 
(rabbit anti-mouse IgG antibody, 1：250) was then applied 
for 10 minutes at the room temperature, and binding of the 
primary antibody was detected and visualized by streptavi-
dine-biotin immunoperoxidase with the use of a polyvalent 
immuno-peroxidase kit(DAKO Co., Carpinteria, CA, USA) 
with diaminobenzidine, following the manufacturer’s proce-
dure. Sections were counterstained with Mayer’s hematoxylin.  
 
Statistical analysis 
Statistical analysis was performed by ANOVA using the 
Statistical Package for Social Science Statview Package(SPSS 
Inc., Chicago, IL, USA) with a p value<0.05 considered stati-
stically significant.  
 
Results 
 
Expression of MPG mRNA by RT-PCR 
The level of MPG mRNA expression in grade IV tumors 
increased about 2.3-fold above brain tissues adjacent to 
tumor(Fig. 1, 2), which was significant statistically(p<0.05). 
As compared with grade II and III astrocytic tumors, grade IV 
tumors showed a significantly higher level of MPG mRNA 
expression(p<0.05)(Fig. 2). However, there was no signifi-
cant difference of MPG mRNA expression between grade II 
and III astrocytic tumors and brain tissues adjacent to tumor 
(p>0.05).  
Cellular localiza- 
tion of MPG mRNA 
by in situ hybridiza-
tion technique 
MPG mRNA was 
constantly expressed 
in cytoplasms of tu-
mor tissues and ad-
jacent brain tissues 
(Fig. 3A, B). The 
expression of MPG 
mRNA in normal 
glial tissues was con-
firmed by in situ hy-
bridization techni-
ques.  
 
Intracellular loca-
lization and expre-
ssion of MPG pro-
tein by immuno-
histochemistry 
Immunostaining 
of MPG protein was 
not observed both in 
the nucleus and cy-
toplasm of brain ti-
ssues adjacent to tu-
mor(Fig. 4A, C, E). 
However, MPG was 
strongly stained in 
the nucleus of astro-
cytic tumor tissues 
regardless of tumor 
grade, not in the cy-
toplasm(Fig. 4B, D, 
F). We could not de-
tect the significant 
difference of MPG 
localization and the 
expression level bet-
ween different gra-
des of astrocytic tumors. 
 
Discussion 
 
DNA repair enzyme, N-methylpurine-DNA glycosylase 
(MPG) and carcinogenesis 
MPG is one of a growing list of enzymes responsible for 
Re
la
tiv
e 
ex
pr
es
sio
n 
of
 M
PG
 m
RN
A
 
8 
7 
6 
5 
4 
3 
2 
1 
0 
Normal tissues(n=7) 
Grade II-III(n=20) 
Grade IV(n=12) 
MPG 
 
 
HPRT 
N    III    M   N    II    N    IV   M   N    III    N    IV 
Fig. 1. RT-PCR products of N-methylpurine DNA glycosylase 
(MPG) and hypoxanthine-guanine phosphoribosyltransferase 
(HPRT) mRNA from cDNA. The same amount of cDNA was am-
plified at different cycles. The bands corresponding to MPG is
603bp and HPRT is 225bp. Lane “N” represents PCR products of 
brain tissues adjacent to tumor at cycle numbers 30. Lane “II, 
III, and IV” represents PCR products of tumor tissues according
to grade. “M” represents DNA size marker.  
Fig. 2. mRNA ratios of N-methylpurine 
DNA glycosylase(MPG) over hypoxan-
thine-guanine phosphoribosyltransferase 
(HPRT) in astrocytic tumor tissues accor-
ding to grade and adjacent brain tissues. 
The relative mRNA level was calculated 
by laser densitometer. The level of MPG 
transcripts in grade IV increased about 
2.3-fold above adjacent brain tissues, 
which was significant statistically(p< 
0.05). As compared with grade II and 
III astrocytic tumors, grade IV tumors 
showed a significantly higher level of 
MPG expression(p<0.05).  
A 
B 
C 
Fig. 3. Cellular localization of N-methyl-
purine DNA glycosylase(MPG) mRNA 
by in situ hybridization technique. MPG 
mRNA is constantly expressed in adja-
cent brain tissue(A) and astrocytic tu-
mor tissues(B)(Original magnification
×400). However, it is not detected in 
the adjacent brain tissues using sense 
strand probe(C). Dark arrows indicate 
expression of MPG mRNA in the cyto-
plasm. 
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the recognition and excision of altered bases in the first step 
of the base excision repair(BER) pathway11,22). In the simplest 
form of BER, the resulting abasic site is then repaired by the 
sequential action of an AP endonuclease that generates a sin-
gle-strand break, the removal of the 5’-terminal deoxyribose 
phosphate residue, insertion of a single nucleotide by DNA 
polymerase β, and finally ligation of the repaired patch by 
DNA ligase I or XRCC1-DNA ligase III. Mammalian MPG 
has been shown to be active against a wide range of modified 
bases in vitro, many structurally unrelated to 3MeA, the sub-
strate after which the enzyme was first named16). Engelward 
et al.9) have genetically engineered animals deficient in MPG, 
a DNA glycosylase that removes a broad spectrum of base 
damages, including, but likely not limited to, 3-methyladenine, 
7-methylguanine, 1-N6-ethenoadenine, hypoxanthine, and 8-
oxo-7,8-dihydroguanine.  
Cells are under constant threat from a great variety of in-
duced structural alterations to their DNA, which could lead 
to high and deleterious mutation rates as well as to cytotoxic 
effects. Endogenous damage to DNA occurs in consequence 
to hydrolysis, lipid peroxidation events and formation of other 
reactive small molecules intracellularly. Since endogenous 
DNA damage occurs at a frequency of about 20,000 events 
per human cell per day18), a high spontaneous mutation fre-
quency might be expected to result from such error-prone 
repair, in addition to the mutagenic threat resulting from tardy 
DNA glycosylase excision of miscoding lesions, such as dea-
minated adenines. The significant turnover of DNA due to the 
excision of endogenous lesions might to expect to contribute 
to the carcinogenic process in mammalian cells, unless special 
mechanisms exist to increase the accuracy of BER19).  
 
Spatial expression of MPG in brain and its tumori-
genesis 
Mammalian cells actively regulate DNA repair enzymes 
and genes during cell proliferation. DNA repair pathways are 
expressed in the cell cycle in a defined temporal pattern re-
lative to the induction of DNA replication36). The MPG ex-
pression was initially identified by virtue of temporal and 
spatial regulation in protein level33,34) and spatial regulation 
in mRNA level8,14). The MPG expression is known tissue-
specific and developmental stage-specific variation14). The 
MPG mRNA level in whole embryo is the highest in day 
14.5 post coitum and apparently declined until the end of 
gestation14). These results suggest that the levels of MPG 
mRNA in embryonic tissues during embryogenesis may re-
flect the levels of cell proliferation in such tissues. Engelward 
et al.8) reported the MPG mRNA levels in various tissues of 
adult mice with the testis and heart showing the highest and 
lowest level among tested organs in adults. XPBC/ERCC-3, 
another DNA repair gene, has shown relatively high levels of 
mRNA in the testis, suggesting that there may be a general 
increase in the level of DNA repair in germline cells35). Mit-
chell and Hartman21) reported that proliferating cells from 
organs and embryos have a greater DNA repair capacity than 
terminally differentiated and nonproliferating cells. In brain 
cells that are not undergoing DNA replication, DNA repair is 
maintaining nucleotide sequences of genomic DNA over 
time. Kim et al.16) reported MPG expression in the brain was 
relative high in 1-week after birth, and the level remained 
low in day 400 mature adults, suggesting that brain tissue is 
terminally differentiated and nonproliferating tissues. Ho-
wever, DNA damage from exogenous or endogenous muta-
gens, above remarked, may be a more serious problem for 
brain cells than other somatic cells despite available mecha-
nisms for avoiding and repairing such damage3,20,28,30). DNA 
repair enzymes, including AP endonuclease, DNA poly-
merase β, XRCC1/DNA ligase III, PCNA(proliferating cell 
nuclear antigen), FEN1(5’-flap endonuclease), MGMT(O6-
methylguanine-DNA methyltransferase), NTH(thymine gly-
col DNA glycosylase), and OGG(8-oxo-guanine DNA gly-
cosylase), may be associated with brain tumorigenesis. Herein, 
we first report that MPG mRNA level in grade IV astrocytoma 
was significantly higher than that in tumor-adjacent brain 
tissues. Also, MPG mRNA level in grade IV astrocytomas 
was definitely higher than that in grade II-III astrocytomas. 
Fig. 4. Immunohistochemical stains for N-methylpurine DNA 
glycosylase(MPG) in tumors and corresponding brain tissues 
adjacent to tumor of the same patients. A, C and E are the
adjacent brain tissues of tumor case B, D and F respectively.
Brain tissues adjacent to tumor are negative for MPG protein
(Original magnification×200). B：Grade II astrocytoma. Tumor 
cells show nuclear positivity for MPG protein(Original magnifi-
cation×200). D：Grade III astrocytoma. The nuclei of tumor
cells demonstrate strong positivity for MPG protein, contrasted
to negative staining of endothelial cells in intervening blood 
vessels(Original magnification×200). F：Atypical tumor cells of 
grade IV astrocytoma show diffuse, strong nuclear positivity
(Original magnification×200). (arrow)：endothelial cell. 
A B 
C D 
E F 
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These facts means that altered MPG mRNA expression is 
closely associated with brain tumorigenesis, perhaps advanced 
stage. Direct estimation of MPG enzyme activity in tumor 
tissues will be helpful for association with tumorigenesis.  
 
Intracellular localization and regulation of MPG in 
brain 
Although RT-PCR assay showed the average mRNA levels 
of MPG in the biopsy tissues, it has limitation in determining 
the distribution of MPG mRNA in individual cells. To ex-
amine the cellular distribution of MPG, RNA in situ hybridi-
zation technique was used. Surprisingly, we found that the 
MPG mRNA localization and the level of tumor adjacent 
brain tissues were similar to that of tumor tissues by RNA in 
situ hybridization techniques. Moreover, the difference of 
MPG mRNA level between tumor-adjacent brain tissues and 
grade II-III tumor tissues by RT/PCR was not statistically 
significant. MPG mRNA might be ready for defense to DNA 
damage in normal astrocytic cells as well as astrocytic tumor 
cells. MPG protein was expressed only in the nucleus of the 
astrocytic tumor tissues. However, MPG protein expression 
in tumor-adjacent brain tissues was not found both in the 
nucleus and cytoplasm. These results suggest that MPG gene 
expression might be controlled by posttranscriptional or tran-
slational level at least in the astrocytic tissues of brain. Ho-
wever, our knowledge of the level and sites of MPG expre-
ssion in patients are limited currently. It is useful to know the 
control level of MPG gene expression by investigation of the 
changes in DNA repair activities both mitochondrial and 
nuclear extracts.  
Recently, Sohn et al.29) reported that the intracellular ex-
pression and localization of MPG altered in cervical neoplasia. 
Granular positivity of MPG was notable in the perinuclear 
regions of the cytoplasm in human papilloma virus-infected 
invasive cervical carcinoma. However, the expression of MPG 
has not been studied yet in the brain tumor patients. Therefore, 
in this study, it was examined whether MPG protein was 
expressed in the cytoplasm or the nucleus of brain tumor 
tissues. We provide evidences that MPG protein is not found 
in brain tissues adjacent to tumor, but rather is found in nu-
clear localization of the astrocytic tumor tissues. The nuclear 
localization means that MPG maybe transported from cyto-
plasm to nucleus for DNA repair. Nuclear localization of 
MPG protein in astrocytic tumors is different from cytoplasmic 
localization of MPG protein in cervical carcinoma. How can 
it explain the difference? There is no definite clue for proper 
explanation of the nuclear MPG protein localization. Cool 
and Sirover5) reported that the immunocytochemical localiz-
ation of BER enzyme uracil DNA glycosylase was examined 
as a function of cell proliferation. During the proliferation, 
there was an increase in glycosylase activity in each of the 
subcellular fractions. These results suggest a correlation be-
tween the proliferative state of normal human cells and the 
preferential nuclear or perinuclear localization of an immun-
ocytochemically reactive glycosylase protein. Further, imm-
unofluorescence of the nuclear enzyme may be dependent on 
defined conformational states of that nuclear glycosylase in 
the cell cycle. In MGMT, Lim and Li15) reported a study 
showing a possible two step-model for the nuclear localization 
of the 21kDa human protein. The first step is the translocation 
of the protein from the cytosol to the nucleus. This appears 
to require the nuclear targeting property associated with the 
holoprotein in combination with a cellular factor to effect the 
nuclear translocation of MGMT. The second step involves 
the nuclear retention of MGMT to prevent its export from 
the nucleus. This requires a basic region(PKAAR, codons 
124-128) that can bind to the non-diffusible DNA elements 
in the nucleus. However, there has not been known holoprotein 
or specific region of codons in MPG. Further studies about 
nuclear localization of MPG protein are warranted.  
 
Conclusion 
 
In conclusion, the level of MPG mRNA and intracellular 
localization in astrocytic tumor tissues was changed. The 
increased expression and subcellular localization was shown 
to be associated with tumorigenesis as well as increased su-
sceptibility to DNA damage. Further studies in vitro are warr-
anted for documentation of control of MPG gene in astrocytic 
tumors.  
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